4041 Forest Park Avenue
C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration.
We formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, and LifeTech Research, a Maryland-based technology research and commercialization firm (www.lifetechresearch.com). We reside at the Center for Emerging Technologies in St. Louis.
Founders: David Holtzman, Randall Bateman and Joel B. Braunstein
Founder and CEO: Joel B. Braunstein
Please click here for C2N Diagnostics job opportunities.